A Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population

The goal of this clinical study is to investigate the efficacy of a Bragg Apple Cider Vinegar (ACV) liquid on postprandial glucose (PPG) excursion compared to a placebo following a standardized acute carbohydrate load. The main question it aims to answer is: Is there a difference in the incremental area under the curve (iAUC) (from 0 - 120 mins following administration) for venous blood glucose between Bragg ACV liquid and placebo following an acute carbohydrate load. Participants will \[describe the main tasks participants will be asked to consume 750 mg of Bragg Apple Cider Vinegar (ACV) liquid or water and undergo a blood draw to measure glucose, insulin, and future analysis markers.

NCT Number	NCT07043478
Lead Sponsor	Bragg Live Food Products Collaborators: KGK Science Inc.
Conditions	Healthy, Blood Glucose
Enrollment	24 participants
Start Date	2025-08-05
Primary Completion	2026-03-22 (estimated)
Study Completion	2026-03-22 (estimated)
Updated on ClinicalTrials.gov	2026-07-08